Health Care·Biotechnology 매출 $29.4B순이익 $8.5BFY2025
Health Care·Health Care Facilities 매출 $75.6B순이익 $6.8BFY2025
Health Care·Health Care Distributors 매출 $13.2B순이익 $398.0MFY2025
Health Care·Managed Health Care 매출 $129.7B순이익 $1.2BFY2025
Health Care·Health Care Equipment 매출 $4.3B순이익 $1.1BFY2025
Health Care·Biotechnology 매출 $5.1B순이익 $1.3BFY2025
Health Care·Life Sciences Tools & Services 매출 $16.3B순이익 $1.4BFY2025
Health Care·Health Care Equipment 매출 $10.1B순이익 $2.9BFY2025
Health Care·Pharmaceuticals New Brunswick, New Jersey 매출 $94.2B순이익 $26.8BFY2025
Health Care·Health Care Services Burlington, North Carolina 매출 $14.0B순이익 $876.5MFY2025
Health Care·Pharmaceuticals 매출 $65.2B순이익 $20.6BFY2025
Health Care·Health Care Distributors 매출 $403.4B순이익 $4.8BFY2026
Health Care·Health Care Equipment 매출 $33.5B순이익 $4.7BFY2025
Health Care·Pharmaceuticals 매출 $65.0B순이익 $18.3BFY2025
Health Care·Biotechnology 매출 $1.9B순이익 -$2.8BFY2025
Health Care·Life Sciences Tools & Services 매출 $4.0B순이익 $869.2MFY2025
Health Care·Pharmaceuticals 순이익 $7.8BFY2025
Health Care·Health Care Equipment 순이익 $247.1MFY2025
Health Care·Biotechnology 매출 $14.3B순이익 $4.5BFY2025
Health Care·Health Care Equipment 매출 $5.1B순이익 $1.4BFY2025
Health Care·Health Care Equipment 매출 $2.9B순이익 $241.2MFY2025
Health Care·Health Care Technology 매출 $8.3B순이익 $1.6BFY2025
Health Care·Health Care Equipment 매출 $5.5B순이익 $614.6MFY2025
Health Care·Health Care Equipment 매출 $25.1B순이익 $3.2BFY2025
재무 지표(매출·순이익 등)는 미국 증권거래위원회(SEC) 공시(EDGAR) 기준 최근 회계연도 데이터입니다. 정보 제공 목적이며 투자 권유가 아닙니다.